Coriolis Pharma Research GmbH
About Coriolis
Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products.
As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients.
We offer a large selection of services for all types of biopharmaceuticals, including proteins, peptides, peptides, nucleic acids, gene- and cell therapy products, vaccines and virus(-like) particles up to biosafety level S2.
Advertisement
Product portfolio of Coriolis
News about Coriolis
Here you will find Coriolis Pharma Research GmbH
Last viewed contents
Rentschler Biopharma SE - Laupheim, Germany
Novozymes Biopharma Signs License Agreement with GE Healthcare to Produce and Sell Protein A
Biotech has Positive Year Despite Weak Fourth Quarter Performance - Burrill looks back at 2007
Nanoscale ruler reveals organization of the cell membrane - Freiburg biologists measure distances and the arrangement of membrane molecules in nanometer range
Australia’s Top 20 cancer drugs to reach sales of $1 billion by 2018
Tripos to Build One of the Leading Informatics-Driven Drug Discovery Laboratories in Europe - - State-of-the-Art Chemical Synthesis Facilities to be Built in Cornwall, England -
5 Leading Multinationals Announce R&D Projects for Ireland - Bristol-Myers Squibb Company, Pfizer Inc., Genzyme Corporation, Xilinx Inc. Citigroup are investing a total of EUR 53.25 million
Pesticides and other common chemical pollutants are toxic to our ‘good’ gut bacteria
Munich-based lab automation startup raised €2.77M - AI-driven biotech research: Connected labs for faster scientific progress
How machine learning, data integration and AI contribute to better strategies in the fight against pathogens - Researchers develop a new machine learning approach
Gene_therapy
